ATGE Stock Recent News
ATGE LATEST HEADLINES
ATGE's second-quarter fiscal 2025 results are aided by strong enrollment growth and strategic initiatives.
Adtalem Global Education Inc. (NYSE:ATGE ) Q2 2025 Earnings Conference Call January 30, 2025 5:00 PM ET Company Participants Jay Spitzer - Vice President of Investor Relations Steve Beard - Chief Executive Officer Bob Phelan - Chief Financial Officer Conference Call Participants Alexander Paris - Barrington Research Associates, Inc. Jeffrey Silber - BMO Capital Markets Steven Pollack - Robert W. Baird & Co. Operator Greetings, and welcome to the Adtalem Global Education Second Quarter 2025 Earnings Call.
Adtalem Global Education (ATGE) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.23 per share a year ago.
CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Second Quarter Fiscal Year 2025 Results; Guidance Raised.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Adtalem (ATGE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE) will release its second quarter fiscal year 2025 results on Thursday, Jan. 30, 2025.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Adtalem Global Education focuses on medical and veterinary education, showing solid profitability and potential growth in a booming healthcare industry. Despite a current ratio below 1.0, ATGE maintains a reasonable price/book ratio and generates significant operating cash flow, indicating financial stability. Risks include reliance on government financial aid, maintaining accreditation, and ensuring student placements in healthcare jobs, which are crucial for sustaining reputation and revenue.